Home / Health / Is $1125 hepatitis tablet from Bay Area drugmaker value it?

Is $1125 hepatitis tablet from Bay Area drugmaker value it?

  • Gilead Sciences won sovereign capitulation for a drug Harvoni, a once-a-day Hepatitis C pill, that has a argumentative $1,125 cost tag. Photo: Gilead Sciences, Courtesy Photo






Photo: Carlos Avila Gonzalez, The Chronicle

Scott Barnes in his San Luis Obispo, Calif., home with only some of a remedy drugs he takes on Wednesday, Apr 30, 2014. Barnes is a Vietnam War army maestro who suspects he held hepatitis C (before it was famous by that name) toward a finish of a fight (1973) though wasn’t strictly diagnosed until a 2000s. He was means to remonstrate his VA doctors to assistance him get on a fast of Sovaldi, a drug grown by Gilead Sciences, that is hailed as a heal for hepatitis C. He has theatre IV hep C, and sees this diagnosis as his final chance.

Scott Barnes in his San Luis Obispo, Calif., home with only some of…



Photo: Carlos Avila Gonzalez, The Chronicle

Scott Barnes binds a inscription of Sovaldi in his San Luis Obispo, Calif., home on Wednesday, Apr 30, 2014. Barnes is a Vietnam War army maestro who suspects he held hepatitis C (before it was famous by that name) toward a finish of a fight (1973) though wasn’t strictly diagnosed until a 2000s. He was means to remonstrate his VA doctors to assistance him get on a fast of Sovaldi, a drug grown by Gilead Sciences, that is hailed as a heal for hepatitis C. He has theatre IV hep C, and sees this diagnosis as his final chance.

Scott Barnes binds a inscription of Sovaldi in his San Luis Obispo,…



Photo: Carlos Avila Gonzalez, The Chronicle

Scott Barnes’s army print during Fort Ord from 1973, that hangs in his San Luis Obispo, Calif., home on Wednesday, Apr 30, 2014. Barnes is a Vietnam War army maestro who suspects he held hepatitis C (before it was famous by that name) toward a finish of a fight (1973) though wasn’t strictly diagnosed until a 2000s. He was means to remonstrate his VA doctors to assistance him get on a fast of Sovaldi, a drug grown by Gilead Sciences, that is hailed as a heal for hepatitis C. He has theatre IV hep C, and sees this diagnosis as his final chance.

Scott Barnes’s army print during Fort Ord from 1973, that hangs in his…



After jolt adult a health caring attention with a $1,000 hepatitis C pill, Gilead Sciences of Foster City won capitulation Friday for a new chronicle of that diagnosis that works faster, drops a common injections and boasts an already-controversial $1,125 cost tag.

The new daily inscription Harvoni costs $94,500 for 12 weeks and $63,000 for 8 weeks — both cheaper than some existent hepatitis C treatments, according to a drugmaker. But some studious advocates are already dissapoint about a cost after scarcely sickening opposite Gilead’s initial hepatitis C therapy, Sovaldi, that became a best-selling new drug ever when it strike a marketplace late final year during $84,000 for 12 weeks.


Harvoni, that combines Sovaldi and a new drug called ledipasvir, is approaching to pull Gilead’s altogether hepatitis C drug sales to $12 billion this year and some-more than $15 billion subsequent year, pronounced Michael Yee, a biotechnology researcher during RBC Capital Markets.

“It is a vital breakthrough to have nonetheless another fast that takes dual drugs and combines it into one, and shortens a diagnosis of caring for patients,” he said.

Debates over cost

Sales of Sovaldi were $2.3 billion in a initial entertain and $3.5 billion in a second, putting it on lane to turn one of a world’s best-selling medicines. At a same time, a success — it can radically heal some-more than 80 percent of patients with few side effects — has strong concerns about society’s ability to compensate for it.

Those debates will roughly positively grow louder now that a Food and Drug Administration has authorized Harvoni, that treats a many common aria of hepatitis C in a United States (Sovaldi treats this aria of a virus, among others). Gilead’s batch finished Friday down 2 percent to $103.73 a share, a day in that many vital markets declined about 1 percent.

In clinical trials, Harvoni marinated 94 to 99 percent of patients in 8, 12 and 24 weeks, depending on a patients’ prior diagnosis story and either they had liver scarring. In a poignant achievement, patients were marinated though a need for a normal hepatitis C drugs interferon and ribavirin, that had to be taken with Sovaldi.

Because Sovaldi can't be taken alone, a loyal cost is aloft than $84,000. A 12-week fast of Sovaldi, interferon and ribavirin is about $94,700. Sovaldi is also mostly taken with another hepatitis C medication, Johnson Johnson’s Olysio, during a sum cost of roughly $150,000.

Harvoni costs reduction than both options, Yee noted.

Long-term savings

Gilead has continued to disagree that a heal achieved in a few months is reduction costly than a costs of a disease’s complications serve down a road, such as treatments for liver cancer or liver transplants.

“We trust a cost of Harvoni reflects a value of a medicine,” pronounced Michele Rest, a Gilead spokeswoman, in an e-mail. “Unlike long-term or unfixed treatments for other ongoing diseases, Harvoni offers a heal during a cost that will significantly revoke hepatitis C diagnosis costs now and broach poignant health caring assets to a health caring complement over a long-term.”

To John Rother, CEO of a National Coalition on Health Care and an competition of rising drug prices, Harvoni might be comparatively cheaper — though it stays costly in comprehensive terms.

“At that price, it’s simply not affordable to millions of Americans,” he said. “Medicaid is going to have genuine difficulty profitable for it, a (Veterans Affairs) complement is going to have genuine difficulty profitable for it, private word is going to have difficulty profitable for it. we consider they missed an event to put a lifesaving drug within a strech of many Americans.”

3 million cases in U.S.

More than 3 million Americans are estimated to have hepatitis C, and a economics of treating many of them with Sovaldi has put vigour on payers.

States customarily contingency cover drugs from companies that attend in Medicaid’s drug remission program, that includes Gilead. The association pronounced in a new discussion call that 47 states are covering a drug for their Medicaid populations, though in an bid to cut costs, about half, including California, have implemented manners that patients contingency accommodate before a alloy can allot Sovaldi. Typically, those criteria prioritize patients who are in a late stages of a illness and have serious liver repairs — a theatre that opponents contend is too late. Most recently, Oregon threatened to tie restrictions.

Payers and studious advocates had been anticipating for some service once Gilead’s rivals, such as AbbVie and Merck, expelled their possess hepatitis C therapies during reduce prices. But that might not happen.

“So far,” Rother said, “we have no denote during all that a competing companies are meditative about competing on price.”

Stephanie M. Lee is a San Francisco Chronicle staff writer. E-mail: [email protected] Twitter: @stephaniemlee

Article source: http://www.sfgate.com/health/article/Is-1-125-hepatitis-pill-from-Bay-Area-drugmaker-5815341.php

Scroll To Top